Yusuke Mizukami Selected Research

Yusuke Mizukami Research Topics

Disease

43	Neoplasms (Cancer) 10/2023 - 03/2004
15	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2002
8	Adenocarcinoma 08/2022 - 08/2010
8	Colonic Neoplasms (Colon Cancer) 04/2022 - 03/2004
6	Carcinogenesis 01/2020 - 06/2005
6	Hypoxia (Hypoxemia) 08/2010 - 03/2004
5	Inflammation (Inflammations) 04/2022 - 09/2010
4	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 05/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 11/2018
3	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 10/2007
2	Disease Progression 11/2023 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022 - 09/2010
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 01/2016
2	Pancreatitis 01/2022 - 11/2021
2	Hemorrhage 04/2021 - 10/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 12/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Infections 04/2014 - 08/2010
1	Stomatitis 01/2024
1	Multiple Myeloma 11/2023
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 01/2023
1	Pancreatic Intraductal Neoplasms 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2022
1	Lymphoma (Lymphomas) 09/2022
1	Cytomegalovirus Infections (Inclusion Disease) 09/2022
1	Gastritis 07/2022
1	Dysbiosis 04/2022
1	Liver Diseases (Liver Disease) 03/2022
1	Epstein-Barr Virus Infections 03/2022
1	Pancytopenia 03/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Wounds and Injuries (Trauma) 11/2021
1	Ascites 08/2021
1	Triple Negative Breast Neoplasms 05/2021
1	Hemophilia A (Haemophilia) 04/2021

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 03/2004
7	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 03/2008
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2004
5	MucinsIBA 01/2023 - 09/2009
4	CateninsIBA 01/2023 - 01/2020
4	Messenger RNA (mRNA)IBA 01/2022 - 03/2004
4	Biomarkers (Surrogate Marker)IBA 08/2021 - 10/2017
4	Cell-Free Nucleic AcidsIBA 06/2021 - 10/2017
4	Gemcitabine FDA Link 10/2009 - 03/2004
3	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2022
2	Long Noncoding RNAIBA 02/2024 - 01/2021
2	SteroidsIBA 01/2024 - 09/2022
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023 - 05/2004
2	C-Reactive ProteinIBA 09/2022 - 04/2014
2	NivolumabIBA 01/2022 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 06/2021 - 11/2018
2	Cyclin D1IBA 01/2021 - 03/2005
2	Phosphotransferases (Kinase)IBA 07/2020 - 01/2002
2	LigandsIBA 01/2019 - 01/2010
2	Dextrans (Dextran)FDA Link 08/2012 - 11/2011
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 08/2012 - 11/2011
2	CytokinesIBA 11/2011 - 09/2005
2	Transcription Factors (Transcription Factor)IBA 02/2009 - 03/2004
2	p38 Mitogen-Activated Protein KinasesIBA 09/2005 - 03/2004
2	CaspasesIBA 03/2004 - 01/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2023
1	Sucrose (Saccharose)IBA 04/2023
1	ChromatinIBA 04/2023
1	VimentinIBA 01/2023
1	12,13- dihydro- N- methyl- 6,11,13- trioxo- 5H- benzo(4,5)cyclohepta(1,2- b)naphthalen- 5,12- imineIBA 04/2022
1	Volatile Fatty AcidsIBA 04/2022
1	propionic acid (potassium propionate)IBA 04/2022
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022
1	Exosome Multienzyme Ribonuclease ComplexIBA 01/2022
1	CarbohydratesIBA 01/2022
1	AntigensIBA 01/2022
1	CeruletideIBA 11/2021
1	PolyphosphatesIBA 11/2021
1	Carcinoembryonic AntigenIBA 08/2021
1	TransposasesIBA 08/2021
1	AntibodiesIBA 07/2021
1	B7-H1 AntigenIBA 07/2021
1	ErbB Receptors (EGF Receptor)IBA 06/2021
1	osimertinibIBA 06/2021
1	Circulating Tumor DNAIBA 05/2021
1	AutoantibodiesIBA 04/2021
1	Factor VIII (Coagulation Factor VIII)IBA 04/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2004
7	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
3	Pancreatectomy 08/2022 - 05/2008
3	Pancreaticoduodenectomy 01/2022 - 01/2020
2	Neoadjuvant Therapy 01/2023 - 01/2021
2	Chemoradiotherapy 01/2021 - 08/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 08/2016
2	Conservative Treatment 01/2019 - 03/2011
2	Combination Drug Therapy (Combination Chemotherapy) 10/2009 - 01/2006
1	Aftercare (After-Treatment) 04/2023
1	Hematopoietic Stem Cell Transplantation 09/2022
1	Radiotherapy 09/2022
1	Ileostomy 04/2022
1	Transplantation 03/2022
1	Self Expandable Metallic Stents 01/2021